Analyst Update: Applied Optoelectronics Inc, Ligand Pharmaceuticals Inc., and Momenta Pharmaceuticals, Inc.

Analysts are weighing in on Applied Optoelectronics Inc (NASDAQ:AAOI), Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)

Sep 7, 2016 at 3:26 PM
facebook X logo linkedin


Analysts are weighing in on fiber optics expert Applied Optoelectronics Inc (NASDAQ:AAOI), as well as biotech stocks Ligand Pharmaceuticals Inc. (NASDAQ:LGND) and Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Here's a quick roundup of today's brokerage notes on AAOI, LGND, and MNTA.

  • Bullish analyst notes are coming through on AAOI, after the company raised its current-quarter outlook. At least six brokerage firms have raised their price targets on the stock, including Piper Jaffray, which set its mark at $24 -- territory not charted since July 2014. The brokerage firm said it believes the company "is in a position to see impressive growth over the next several quarters." As such, Applied Optoelectronics Inc is up 14.8% at $19.90, and could run higher if short sellers begin to cover. Currently, short interest accounts for one-fourth of the stock's float, or 8.4 times the average pace of trading.
  • LGND is up 5.9% at $114.47, following a price-target increase to $151 from $149 at Roth Capital. Specifically, the brokerage firm said positive mid-stage trial data for Retrophin Inc's (NASDAQ:RTRX) kidney drug, sparsentan -- which LGND holds the rights to -- is "an important win" for both companies. Bullish analyst attention is nothing new for the stock, which boasts four "strong buy" recommendations, versus a single "strong sell." This optimism appears well-deserved, though, since Ligand Pharmaceuticals Inc. sports a roughly 21% year-over-year lead, even after a major pullback last month. 
  • MNTA is sliding after a downgrade to "sell" from "hold" at Maxim. The shares have shed 4% to trade at $11.74, bringing their losses for the year to almost 21%. If Momenta Pharmaceuticals, Inc. continues to struggle on the charts, a round of bearish analyst attention could create additional headwinds. The majority of analysts on Wall Street consider the stock a "strong buy," despite its disappointing performance, without a single "sell" to be found.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI